# Spinal Cord Injury Medicine * **Definition:** A subspecialty of medicine focused on the prevention, diagnosis, treatment, and rehabilitation of individuals with spinal cord injuries, encompassing a multidisciplinary approach to manage the complex medical, psychological, and social needs of patients. * **Taxonomy:** Specialties / Spinal Cord Injury Medicine ## News * Selected news on the topic of **Spinal Cord Injury Medicine**, for healthcare technology leaders * 303 news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/22/2025 | [**New approach to evaluating cases with rheumatic reactions to cancer immunotherapy**](https://medicalxpress.com/news/2025-05-approach-cases-rheumatic-reactions-cancer.html) | [[MedicalXpress]] | | 5/22/2025 | [**Orthopedic surgeon speaker spotlight: Dr. Daniel Choi**](https://www.beckersspine.com/orthopedic/orthopedic-surgeon-speaker-spotlight-dr-daniel-choi/) | [[Beckers Spine Review]] | | 5/21/2025 | [**Rheumatology News**](https://www.medscape.com/index/list_11823_0) | [[Medscape]] | | 5/19/2025 | [**Assistive Devices for Elderly People 2025: Daily Living, Safety at Home, and More - Healthline**](https://www.healthline.com/health/assistive-devices-for-elderly) | [[Healthline]] | | 5/19/2025 | [**Stanford spinal cord specialist dies at 91**](https://www.beckersspine.com/spine/stanford-spinal-cord-specialist-dies-at-91/) | [[Beckers Spine Review]] | | 4/23/2025 | [**Articularis Rheumatology Specialists Announces Grand Opening of New Medical Practice in Smyrna**](https://www.prnewswire.com/news-releases/articularis-rheumatology-specialists-announces-grand-opening-of-new-medical-practice-in-smyrna-302435140.html) | [[PR Newswire]] | | 4/8/2025 | [**Breaking the Stigma: Why Asking for Help Is a Strength in Medical Training**](https://www.medscape.com/viewarticle/breaking-stigma-why-asking-help-strength-medical-training-2025a10008d2) | [[Medscape]] | | 4/8/2025 | [**AmeriCare Medical's Detroit Tigers Opening Day Event Hits a Home Run for Charity**](https://www.prnewswire.com/news-releases/americare-medicals-detroit-tigers-opening-day-event-hits-a-home-run-for-charity-proceeds-benefit-the-michigan-spinal-cord-injury-association-302422450.html) | [[PR Newswire]] | | 4/3/2025 | [**Study finds physicians treating chronic back pain need more education about axial spondyloarthritis**](https://medicalxpress.com/news/2025-04-physicians-chronic-pain-axial-spondyloarthritis.html) | [[MedicalXpress]] | | 3/25/2025 | [**NervGen Pharma to Host Virtual Investor Event - Yahoo Finance**](https://finance.yahoo.com/news/nervgen-pharma-host-virtual-investor-123000283.html) | [[Yahoo Finance]] | | 3/13/2025 | [**Clinical trial tests herpes virus-based therapy for neurogenic bladder in people with spinal cord injury**](https://www.news-medical.net/news/20250312/Clinical-trial-tests-herpes-virus-based-therapy-for-neurogenic-bladder-in-people-with-spinal-cord-injury.aspx) | [[News Medical Net]] | | 1/28/2025 | [**LunaJoy Launches Certification Program to Reinforce Best Practices for Women's and Maternal Mental Health Care**](https://www.prweb.com/releases/lunajoy-launches-certification-program-to-reinforce-best-practices-for-womens-and-maternal-mental-health-care-302361885.html) | [[PRWeb]] | | 1/10/2025 | [**100 great neuro and spine programs - 2024**](https://www.beckershospitalreview.com/lists/100-great-neuro-and-spine-programs-2024.html) | [[Beckers Hospital Review]] | | 1/2/2025 | [**Frances Krauskopf Conley - The Lancet**](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02800-9/fulltext) | [[The Lancet]] | | 12/20/2024 | [**Nogo-A inhibition demonstrates potential for spinal cord injury recovery - News-Medical**](https://www.news-medical.net/news/20241219/Nogo-A-inhibition-demonstrates-potential-for-spinal-cord-injury-recovery.aspx) | [[News Medical Net]] | | 12/9/2024 | [**ICYMI: Highlights From ASPC Congress 2024**](https://www.ajmc.com/view/icymi-highlights-from-aspc-congress-2024) | [[AJMC]] | | 11/27/2024 | [**Medical Exoskeleton Market to grow by USD 2.87 Billion from 2024-2028, driven by rising SCI incidences, with AI transforming the market landscape - Technavio**](https://www.prnewswire.com/news-releases/medical-exoskeleton-market-to-grow-by-usd-2-87-billion-from-2024-2028--driven-by-rising-sci-incidences-with-ai-transforming-the-market-landscape---technavio-302316593.html) | [[PR Newswire]] | | 9/12/2024 | [**NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences**](https://www.globenewswire.com/news-release/2024/09/12/2945567/0/en/NurExone-Biologic-Extends-Global-Reach-with-Presentations-at-Industry-Leading-Conferences.html) | [[Globe Newswire]] | | 9/12/2024 | [**NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences**](https://finance.yahoo.com/news/nurexone-biologic-extends-global-reach-200400051.html) | [[Yahoo Finance]] | | 9/10/2024 | [**New normative neuroimaging library sets standard for brain injury research**](https://www.news-medical.net/news/20240910/New-normative-neuroimaging-library-sets-standard-for-brain-injury-research.aspx) | [[News Medical Net]] | | 9/10/2024 | [**Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research**](https://finance.yahoo.com/news/lifeward-announces-appointment-dr-keith-123000795.html) | [[Yahoo Finance]] | | 8/26/2024 | [**Paralyzed Veterans of America Hosts Annual Healthcare Summit + Expo, A Must-Attend Event for Leaders and Clinicians in Field of Spinal Cord Injury and Disease**](https://www.prnewswire.com/news-releases/paralyzed-veterans-of-america-hosts-annual-healthcare-summit--expo-a-must-attend-event-for-leaders-and-clinicians-in-field-of-spinal-cord-injury-and-disease-302230574.html) | [[PR Newswire]] | | 8/20/2024 | [**Ekso Bionics Announces Receipt of Initial CMS Reimbursement for Ekso Indego Personal**](https://www.morningstar.com/news/globe-newswire/9217422/ekso-bionics-announces-receipt-of-initial-cms-reimbursement-for-ekso-indego-personal) | [[Morningstar]] | | 7/31/2024 | [**Brain Computer Interfaces 2025-2045: Technologies, Players, Forecasts - IDTechEx**](https://www.idtechex.com/en/research-report/brain-computer-interfaces-2025-2045-technologies-players-forecasts/1024) | idtechex.com | | 7/26/2024 | [**Kevin Piette Carried the Olympic Torch Via a Robotic Exoskeleton**](https://www.mddionline.com/equipment/kevin-piette-carried-the-olympic-torch-via-a-robotic-exoskeleton) | [[MDDI]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **ONWARD Medical**: A company focused on spinal cord stimulation therapies to restore movement and function in individuals with spinal cord injuries. - **Brooks Rehabilitation**: A rehabilitation organization recognized for its expertise in treating spinal cord injuries and utilizing advanced technologies. - **Kessler Foundation**: A research organization investigating the impact of social determinants on health outcomes following spinal cord injury. - **Duke University School of Medicine**: Collaborating with Marius Pharmaceuticals to investigate testosterone therapy effects on recovery in spinal cord injury patients. - **NeuroRestore**: A research group developing integrated systems combining neuroprosthetics and rehabilitation robotics for spinal cord injury therapy. - **ONWARD Medical N.V.**: A medical technology company specializing in spinal cord stimulation therapies aimed at restoring movement and function in individuals with spinal cord injuries. - **Dr. Keith E. Tansey**: Director of Clinical Research at Lifeward, with over 30 years of experience in spinal cord injury research and treatment. - **Dignify Therapeutics**: A company developing pharmaceutical approaches for bladder and bowel dysfunction in individuals with spinal cord injuries. - **EPFL**: École Polytechnique Fédérale de Lausanne, involved in developing high-frequency electrical stimulation techniques for spinal cord injury rehabilitation. - **Lineage Cell Therapeutics**: A biotechnology company focused on developing cell therapies for spinal cord injuries and other neurological conditions. - **ANEUVO**: Innovator of the ExaStim Stimulation System, aimed at restoring mobility for individuals with chronic spinal cord injuries. - **NervGen**: A biotechnology company focused on developing therapies for spinal cord injury and nervous system repair. - **Ekso Bionics**: A leading company in the exoskeleton market, developing assistive devices for rehabilitation, particularly for individuals with spinal cord injuries. - **Paralyzed Veterans of America (PVA)**: An advocacy organization for veterans with spinal cord injuries, promoting healthcare access and benefits. - **NurExone Biologic Inc.**: A pharmaceutical company focused on developing exosome-based therapies for spinal cord injuries. - **ReWalk Robotics**: Another key player in the exoskeleton market, focusing on self-assist devices that enhance mobility for individuals with spinal cord injuries. - **ReWalk Robotics Ltd. (Lifeward)**: A company focused on developing personal exoskeletons for spinal cord injury patients, enhancing mobility and independence. ### Partnerships and Collaborations - **Select Medical and UPMC**: They are collaborating to open a new rehabilitation hospital that will feature advanced rehabilitation technologies for patients recovering from spinal cord injuries. - **Grady Health System**: Launched a new inpatient rehabilitation unit to provide specialized care for patients recovering from spinal cord injuries. - **Lifeward and Dr. Tansey**: Collaboration to enhance clinical research and partnerships for exoskeleton use in spinal cord injury patients. - **Nexus Children's Hospital and Pediatric Acute Care Associates**: This partnership aims to enhance continuity of care for pediatric patients transitioning from intensive care to transitional care, specifically addressing needs related to spinal cord injuries. - **Dignify Therapeutics and University of Kentucky**: Collaboration to develop new pharmaceutical approaches for bladder and bowel control in spinal cord injury patients. - **Lineage Cell Therapeutics and Roche**: Partnership aimed at advancing cell transplant therapies for spinal cord injuries. - **NervGen and Key Opinion Leaders**: NervGen is collaborating with experts to discuss the treatment landscape for spinal cord injury and the clinical trial of NVG-291. - **Marius Pharmaceuticals and Duke University**: Partnering to study the effects of testosterone replacement therapy on recovery outcomes in spinal cord injury patients. - **NurExone and European Medicines Agency**: NurExone received Orphan Medicinal Product Designation for its ExoPTEN therapy, facilitating faster market entry for spinal cord injury treatments. - **Carnegie Mellon University and Meta**: Collaborative project to enhance accessibility for individuals with varying motor abilities through wearable sensing technology. - **Nasoni and Eastern Virginia Medical School**: Conducting clinical trials for smart faucet technology aimed at improving hygiene for patients with cognitive impairments. - **XLerateHealth and University of Kentucky**: Selected innovators to participate in the NIH-funded I-RED program focusing on medical devices and therapeutics. - **Intelligent Product Solutions and Neuvotion**: Expanded partnership to support the market launch of Neuvotion's first product, NeuStim. - **NurExone and GMP-compliant CRO**: Partnership to validate ExoPTEN for commercial-grade manufacturing. ### Innovations, Trends, and Initiatives - **Immunotherapy Approaches**: Research at WashU Medicine is exploring engineered immune cells to minimize spinal cord injury damage, indicating a trend towards immunotherapy in spinal cord injury treatment. - **Neural Stem Cell Transplantation**: Clinical trials demonstrating long-term safety and feasibility for treating chronic spinal cord injuries. - **NISCI Trial**: Research showing that antibodies can enhance rehabilitation outcomes for individuals with acute spinal cord injuries. - **ARC Therapy by ONWARD Medical**: A spinal cord stimulation therapy aiming to restore movement and function in spinal cord injury patients, currently in clinical studies. - **Medical Exoskeletons**: The market for medical exoskeletons is expanding with advancements in technology, including lighter designs and AI integration to improve functionality for spinal cord injury rehabilitation. - **Neuroprosthetics and Robotics Integration**: A system that combines implanted neuroprosthetics with rehabilitation robotics to improve therapy outcomes for spinal cord injury patients. - **Spinal cord stimulation**: ONWARD Medical's ARC Therapy has received multiple FDA Breakthrough Device Designations, indicating significant advancements in restoring movement. - **Brain-computer interface (BCI)**: ONWARD Medical is developing BCI technologies to restore thought-driven movement in stroke and spinal cord injury patients. - **3D-Printed Electroconductive Implants**: Researchers at RCSI University have developed a new implant that transmits electrical signals to aid nerve cell repair after spinal cord injuries. - **Brain-Computer Interfaces (BCIs)**: ONWARD Medical's ARC-BCI System aims to restore thought-driven movement in individuals with spinal cord injuries, showcasing the potential of BCI technology in rehabilitation. - **ExaStim Stimulation System**: A non-invasive device under clinical testing aimed at restoring motor functions in spinal cord injury patients. - **AI in Rehabilitation**: Rothman Orthopaedic Institute is utilizing AI to enhance billing efficiencies and improve surgical outcomes in spinal procedures. - **Exosome-based therapies**: NurExone is advancing exosome therapies for neuron regeneration post-spinal cord injury, showcasing at major conferences. - **EG110A Therapy**: A modified herpes virus therapy being tested for treating neurogenic bladder in spinal cord injury patients, aiming for long-lasting effects. - **Robotic exoskeletons**: Wandercraft's self-balancing exoskeleton has been FDA cleared, enhancing rehabilitation for spinal cord injury patients. - **Exosome Manufacturing Advancements**: NurExone's improvements in exosome production from stem cells show potential for therapeutic applications in spinal cord injuries. - **High-Frequency Electrical Stimulation**: Developed by scientists to reduce muscle spasticity in spinal cord injury patients, enhancing rehabilitation access. - **Medical Exoskeleton Market Growth**: Projected growth from $1.09 billion in 2024 to $8.70 billion by 2035, driven by advancements in technology and increased awareness. - **Exoskeleton Market Growth**: Projected to grow from $1.09 billion in 2024 to $8.70 billion by 2035, driven by advancements in robotics and increasing demand for mobility solutions. ### Challenges and Concerns - **Access to Advanced Treatments**: The need for better integration of rare diseases into public health strategies, particularly in the context of spinal cord injuries and related complications. - **Social Determinants of Health**: Research indicates individuals in disadvantaged neighborhoods face greater health risks post-spinal cord injury, highlighting the need for public policy interventions. - **Insurance Coverage Disparities**: A study indicates that uninsured patients with spinal cord injuries face significantly worse outcomes, highlighting the impact of insurance status on treatment access and quality. - **Economic disparities**: Research indicates that individuals in economically disadvantaged neighborhoods face greater health risks post-spinal cord injury, highlighting the need for public policy interventions. - **Regulatory Hurdles**: Innovations in spinal cord injury treatments face challenges in meeting regulatory standards for clinical trials. - **Healthcare access in conflict zones**: The ongoing conflict in Gaza has severely disrupted healthcare services, leading to increased rehabilitation needs for spinal cord injury patients. - **Funding Shortfalls**: PVA highlights a $12 billion shortfall for healthcare services in fiscal year 2025, risking care for veterans with spinal cord injuries. - **Effectiveness of Current Treatments**: Current rehabilitation methods may be limited without active muscle engagement, highlighting the need for innovative solutions. - **High Costs of Medical Exoskeletons**: Despite the large patient population needing mobility assistance, the market remains niche due to high costs and low awareness. - **High Costs of Exoskeletons**: Despite demand, the medical exoskeleton market remains niche due to high costs and lack of awareness among patients and providers. - **Ethical Concerns with BCIs**: Concerns have been raised regarding the potential misuse of brain-computer interfaces, particularly in military applications, emphasizing the need for ethical considerations in technology deployment. - **Financial Management in Healthcare**: Concerns about financial management practices in healthcare organizations, as seen in the case of Active Care Group, which faced significant debt. - **Regulatory hurdles**: Companies like NurExone and ONWARD Medical face challenges in navigating regulatory pathways for their innovative therapies. ## Related Topics [[Brain Injury Medicine]]